Luminex buys EraGen Biosciences; gains new PCR platform
This article was originally published in Clinica
Executive Summary
Multiplexing specialist Luminex is set to acquire EraGen Biosciences, a privately-held molecular diagnostics company, in a bid to diversify and bulk up its current molecular diagnostics offerings.